FIELD: medicine.
SUBSTANCE: invention describes a method of estimating erythrocyte aggregation that involves erythrocyte recovery from blood and aggregation recording, wherein an aggregation inducer is presented by zinc chloride with erythrocytes being placed in an aggregometer cell with zinc chloride added to the final concentration of 3-10 mM, and a photometric method is used to record a degree of aggregation.
EFFECT: method enables using the new erythrocyte aggregation inducer with known mechanism of cell membrane action.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING ERYTHROCYTE AGGREGATION | 2008 |
|
RU2390778C2 |
| METHOD FOR ERYTHROCYTE AGGREGATION ESTIMATION | 2015 |
|
RU2667009C2 |
| METHOD FOR ASSESSING CHANGE IN SIZE OF RED CELL AGGREGATES | 2016 |
|
RU2691388C2 |
| METHOD OF ASSESSING THE DEGREE OF PRESENCE OF PHOSPHATIDYLSERINE ON THE SURFACE OF ERYTHROCYTE MEMBRANES | 2019 |
|
RU2701520C1 |
| METHOD FOR EVALUATING ALTERED STATE OF ERYTHROCYTIC MEMBRANES | 2002 |
|
RU2238556C2 |
| METHOD OF ESTIMATION OF ERYTHROCYTE MEMBRANE STATE ALTERNATION | 1991 |
|
RU2082968C1 |
| METHOD FOR ASSESSING THE DEGREE OF EXTERNALIZATION OF PHOSPHATIDYLSERINE ON THE SURFACE OF ERYTHROCYTE MEMBRANES | 2021 |
|
RU2768194C1 |
| DIAGNOSTIC TECHNIQUE FOR DISTURBED THROMBOCYTE AGGREGATION ACCOMPANYING MUCOVISCIDOSIS IN CHILDREN | 2013 |
|
RU2533287C1 |
| METHOD FOR THROMBOCYTE AGGREGATION ACTIVITY DETERMINATION FOR PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2619858C1 |
| METHOD OF DETERMINING ANTI-THROMBOTIC EFFECT OF ACETYLSALICYLIC ACID | 2007 |
|
RU2379684C2 |
